Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04947735 · ClinicalTrials.gov registry record · NA

CYPRESS Efficacy and Safety Study Extension

A NA study of Myopia and Juvenile Myopia, sponsored by SightGlass Vision.

Active
Registry status
NA
Development phase
200
Enrollment target
12
Study locations

NCT04947735 is a NA study of Myopia and Juvenile Myopia that is active but no longer recruiting, run by SightGlass Vision. The registered enrollment target is 200 participants, below the 266-participant average among 90 other Myopia trials with a reported enrollment target (25% lower). The trial reports 12 study locations across 11 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04947735, a NA study of Myopia and Juvenile Myopia, is active but no longer recruiting, sponsored by SightGlass Vision.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
12
Study locations

Study Summary

This is an open-label, controlled, multisite, two-arm parallel group clinical trial of 36-month duration to evaluate the continued safety and efficacy of SightGlass Vision Diffusion Optics Technology (DOT) Spectacles in reducing the progression of juvenile myopia.

Conditions Studied

Interventions

  • DEVICE Novel spectacle lens design
  • DEVICE Spectacle lenses

Study Locations (12)

New York

  • SUNY School of Optometry - New York
  • Sacco Eye Group - Vestal

California

  • Golden Optometric Group - Whittier

Florida

  • Omega Vision Center, PA - Longwood

Kansas

  • Kannarr Eye Care - Pittsburg

Louisiana

  • Haik Humble - West Monroe

Missouri

  • Advanced Eyecare PC - Raytown

South Dakota

  • Dunes Eye Consultants - Dakota Dunes

Tennessee

  • Total Eye Care - Memphis

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2021-07-19
Est. Completion 2026-03-31
Phase NA

Sponsor

SightGlass Vision

8 total trials

What the Registry Record Tells You About NCT04947735

The ClinicalTrials.gov registry entry for NCT04947735 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 266-participant average among 90 other Myopia trials with a reported enrollment target (25% lower). The listed sponsor is SightGlass Vision, which has 8 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Myopia appearing as the primary indexed condition, and to 2 interventions - of which Novel spectacle lens design is the first listed.

NCT04947735 reports 12 study locations spanning 11 distinct geographic areas - top geographies include New York, California, Florida.

Frequently Asked Questions

What is clinical trial NCT04947735 about?

NCT04947735 is a clinical study titled "CYPRESS Efficacy and Safety Study Extension". This is an open-label, controlled, multisite, two-arm parallel group clinical trial of 36-month duration to evaluate the continued safety and efficacy of SightGlass Vision Diffusion Optics Technology (DOT) Spectacles in reducing the progression of juvenile myopia.

What is the current status of trial NCT04947735?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2021-07-19. Estimated completion is 2026-03-31.

What conditions does trial NCT04947735 study?

This clinical trial studies the following conditions: Myopia, Juvenile Myopia.

What interventions are being tested in trial NCT04947735?

The interventions under investigation include: Novel spectacle lens design (DEVICE), Spectacle lenses (DEVICE).

Who is sponsoring clinical trial NCT04947735?

This trial is sponsored by SightGlass Vision, which has 8 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04947735 being conducted?

This trial has 12 study locations across California, Florida, Kansas, Louisiana, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Myopia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.